PortfoliosLab logo

Agile Therapeutics, Inc. (AGRX)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS00847L1008
CUSIP00847L100
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$1.27
Year Range$1.09 - $54.80
EMA (50)$2.90
EMA (200)$18.29
Average Volume$1.50M
Market Capitalization$5.22M

AGRXShare Price Chart


Chart placeholderClick Calculate to get results

AGRXPerformance

The chart shows the growth of $10,000 invested in Agile Therapeutics, Inc. on May 27, 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $57 for a total return of roughly -99.43%. All prices are adjusted for splits and dividends.


AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

AGRXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-18.06%-6.21%
YTD-93.50%-18.17%
6M-94.23%-17.47%
1Y-97.65%-8.89%
5Y-61.77%10.04%
10Y-47.20%9.30%

AGRXMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AGRXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Agile Therapeutics, Inc. Sharpe ratio is -0.93. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

AGRXDividend History


Agile Therapeutics, Inc. doesn't pay dividends

AGRXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

AGRXWorst Drawdowns

The table below shows the maximum drawdowns of the Agile Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Agile Therapeutics, Inc. is 99.79%, recorded on Jun 22, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.79%Apr 17, 20151809Jun 22, 2022
-45.35%Jun 25, 2014122Dec 16, 201449Feb 27, 2015171
-20.5%Mar 5, 201515Mar 25, 20158Apr 7, 201523
-9.22%Jun 4, 20142Jun 5, 20144Jun 11, 20146
-3.04%Jun 20, 20141Jun 20, 20141Jun 23, 20142
-2.02%Jun 16, 20141Jun 16, 20141Jun 17, 20142
-1.52%May 30, 20141May 30, 20141Jun 2, 20142
-0.51%Apr 9, 20151Apr 9, 20151Apr 10, 20152
-0.37%Mar 2, 20151Mar 2, 20151Mar 3, 20152

AGRXVolatility Chart

Current Agile Therapeutics, Inc. volatility is 96.45%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Agile Therapeutics, Inc.


Loading data...